Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07386574

Contextualization and Digitalization of WHO's Mental Health Action Gap Intervention Guide Substance Use Disorders Module

Testing a Contextualized and Digitalized WHO's Mental Health Action Gap Intervention Guide Substance Use Disorders Module in Primary Care Settings of Pakistan: A Feasibility Cluster Randomized Controlled Trial

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
300 (estimated)
Sponsor
Pakistan Institute of Living and Learning · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The aim of study is to: 1. To contextualize, adapt, customize and digitalize WHO's Mental Health Gap Action Programme Intervention Guide (e-mhGAP-IG); Substance Use Disorders Module (SUD module) V 2.0 for primary care settings (PCPs) in Pakistan. 2. To test the feasibility and acceotability of the e-mhGAP-IG (SUD module) training program in a feasibility cluster randomized controlled (cRCT) trial to enable mental health services in primary health care settings in Pakistan. The proposed study includes contextualization, adaptation, customization, and a feasibility cRCT of e-mhGAP-IG (SUD module) V 2.0 by constituting a combination of traditional and technological approaches of eHealth (mHealth, blended learning, and telemedicine) enabling mental health services in primary care settings to be well informed and accessible. This intervention will empower 300 Primary Care Physicians (PCPs) based in Primary Care Units (PCUs) from urban settlements and Basic Health Units (BHUs) from rural settlements in three major cities, Karachi, Lahore, and Rawalpindi, Pakistan.

Conditions

Interventions

TypeNameDescription
OTHERmhGap IG SUD Module Intervention Training8 bi-weekly training sessions of e-mhGAP IG SUD Module
OTHERControlRoutine practices or standard of care

Timeline

Start date
2025-01-01
Primary completion
2026-03-01
Completion
2026-06-01
First posted
2026-02-04
Last updated
2026-02-04

Locations

1 site across 1 country: Pakistan

Source: ClinicalTrials.gov record NCT07386574. Inclusion in this directory is not an endorsement.